We recently spoke to Dr. Priyanka Mathur, a visionary healthcare leader with international healthcare experience…
TechPharus
Latest Posts
VC interview: LanceBio VC
We interviewed Ilya Yasny, who is a luminary in the world of venture capitalism, particularly…
iHairium: AI for your hair
We have discussed the new deeptech approach to the hair loss and scalp problems, and…
Why you must consider your next investment into AI in Drug Discovery
Artificial intelligence (AI) is revolutionizing drug discovery by providing novel and efficient ways to identify…
Is the right team your main advantage and key to your success?
Today analyzing your startup team becomes crucial for the success of your venture because it…
Trending HealthTech Accelerators
Healthtech accelerators are programs that provide support and resources to early-stage startups in the healthcare…
HealthTech News
- Digital PCR identifies leukemia patients who can stop drug treatmenton March 27, 2025 at 9:08 pm
Researchers have found that the clinical application of BCR::ABL1 digital PCR can reliably quantify stable deep molecular remission of chronic myeloid leukemia (CML), which will help to determine for which patients chronic drug treatment could potentially be discontinued. This transcript that is unique for CML is more sensitive and accurate than the current standard, real-time quantitative PCR (RT-qPCR), for detecting ultralow levels of residual leukemic disease. Results are reported in The Journal of Molecular Diagnostics.
- Neurons use simple physics to maintain their connections, but these processes change in Alzheimer’s patientson March 27, 2025 at 9:00 pm
Scientists at Auburn University have uncovered a fundamental principle of how brain cells stay connected, and their discovery could change how we understand Alzheimer’s disease. Published in Cell Reports, this study reveals that neurons—the cells that make up our brain—use simple physics to maintain their connections, and that these processes change in Alzheimer’s patients.
- Successful CAR-T cell therapy for end-stage multiple myeloma using advanced cellular product performed in Hong Kongon March 27, 2025 at 8:49 pm
A clinical team has spearheaded the use of CAR-T cell therapy for blood cancers. The researchers recently treated the first myeloma patient with this therapy, resulting in a very good response without severe complications. The expansion of this innovative treatment to myeloma patients offers new hope for those who have not responded to traditional treatment, marking a significant milestone in advancing health care in Hong Kong.
- Study looks at recovery potential in comatose patients who died after halting life-sustaining therapyon March 27, 2025 at 8:49 pm
Most comatose patients resuscitated from cardiac arrest who died after withdrawal of life-sustaining therapy (WLST) were considered by experts to have recovery potential of at least 1%, according to a study published online March 25 in JAMA Network Open.
- Pregnant women advised to avoid mentholated e-cigaretteson March 27, 2025 at 8:49 pm
Vaping during pregnancy is becoming more common, but its impact on early human development is not well understood. A new study by scientists at the University of California, Riverside, now reports that the flavor chemical menthol used in electronic cigarettes could pose risks to a developing baby.